Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • EGFR
    (2)
  • HER
    (2)
  • AChR
    (1)
  • COX
    (1)
  • GPCR19
    (1)
  • MAPK
    (1)
  • MEK
    (1)
  • Src
    (1)
  • Transferase
    (1)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
  • Immune System
    (2)
  • Inflammation
    (2)
  • Nervous System
    (2)
Filter
Search Result
Results for "

T2610

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | All_Pathways
BMS-599626
AC480
T2610714971-09-2
BMS-599626 (AC480) has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
  • $792
35 days
Size
QTY
RMM-46
RMM46
T261031307896-46-3In house
RMM-46 is a reversible covalent inhibitor with high ligand efficiency and selectivity for MSK/RSK family kinases.
  • $293
In Stock
Size
QTY
TargetMol | Citations Cited
RLH 033
RLH-033, RLH033
T26100157097-10-4
RLH 033 is a selective ligand for the sigma 1 recognition site.
  • $1,520
6-8 weeks
Size
QTY
Ro 41-0960
Ro41-0960, Ro-41-0960
T26106125628-97-9
Ro 41-0960 is used as a reversible and orally-active COMT-inhibitor.
  • $142
35 days
Size
QTY
RO5527239
RO-5527239, RO 5527239
T261081354812-99-9
RO5527239 is a potent, orally available GPBAR1 agonist agent.
  • $1,970
8-10 weeks
Size
QTY
Robenacoxib
Onsior
T26109220991-32-2
Robenacoxib (Onsior) is a non-steroidal compound with strong selectivity for cyclooxygenase-2 and anti-inflammatory activity.
  • $63
In Stock
Size
QTY
BMS-599626 2HCL(714971-09-2 Free base)
BMS-599626 2HCL(714971-09-2 Free base), BMS 599626 dihydrochloride, AC480 2HCl
T2610L
BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative. BMS-599626 is an orally available and selective dual inhibitor of HER1 and HER2 with IC50s of 20 and 30 nM, respectively. BMS-599626 inhibits tumor cell proliferation and has the potential to increase tumor BMS-599626 inhibits tumor cell proliferation and has the potential to increase tumor response to radiotherapy.
  • $52
In Stock
Size
QTY